Research by CONVERGE’s Dr. Marian Jarlenski, Sabnum Pudasainy, MS, and Dr. Elizabeth Krans highlights that longer duration and higher dose of buprenorphine treatment during pregnancy were associated w/ improved odds of postpartum bup. continuation and weren't associated w/ adverse neonatal outcomes
about 2 months ago